Condition
Hypertonia, Muscle
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting2
Withdrawn1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05527652Not ApplicableRecruiting
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
NCT03492060Recruiting
Longitudinal Study of Neurogenetic Disorders
NCT06117020Phase 1Completed
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
NCT04188769Not ApplicableWithdrawn
Effect of Local Pressure on Muscle Activity and General Relaxation in Persons With Hypertonia Following Stroke
Showing all 4 trials